1. Home
  2. HCSG vs SVRA Comparison

HCSG vs SVRA Comparison

Compare HCSG & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Healthcare Services Group Inc.

HCSG

Healthcare Services Group Inc.

HOLD

Current Price

$22.53

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

SVRA

Savara Inc.

HOLD

Current Price

$5.13

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCSG
SVRA
Founded
1976
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Assisted Living Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1994
2009

Fundamental Metrics

Financial Performance
Metric
HCSG
SVRA
Price
$22.53
$5.13
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$22.67
$7.33
AVG Volume (30 Days)
692.6K
1.2M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
52.83
N/A
EPS
0.81
N/A
Revenue
$1,837,173,000.00
N/A
Revenue This Year
$7.39
N/A
Revenue Next Year
$5.22
$430.87
P/E Ratio
$26.33
N/A
Revenue Growth
7.08
N/A
52 Week Low
$12.66
$1.89
52 Week High
$24.39
$7.01

Technical Indicators

Market Signals
Indicator
HCSG
SVRA
Relative Strength Index (RSI) 66.46 42.01
Support Level $17.21 $4.95
Resistance Level $22.69 $6.15
Average True Range (ATR) 0.81 0.29
MACD 0.43 -0.09
Stochastic Oscillator 68.08 16.85

Price Performance

Historical Comparison
HCSG
SVRA

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: